MindRank Raises $52 Million In Series B Financing To Advance AI-Native Drug Development - Pulse 2.0

A biotech startup raised $52 million to use AI for developing new medications more efficiently. Growing investment in AI-driven drug discovery signals confidence that this approach could transform how new medicines are created.